Global CRISPR Market Size Study & Forecast by Product & Services (CRISPR Kits & Enzymes, CRISPR Libraries, Other Products, Services) and Application (Drug Discovery, Agriculture) and Regional Forecasts 2022-2032

Description

The global CRISPR market was valued at approximately USD 5.69 billion in 2024 and is expected to expand at a robust compound annual growth rate (CAGR) of 16.50% during the forecast period from 2025 to 2035. CRISPR technology, an advanced gene-editing tool, is revolutionizing the landscape of biotechnology and pharmaceutical research by enabling precise genome modifications. It has broad applications ranging from drug discovery and development to agriculture and biofuel production. This growth trajectory is propelled by increasing investments in genetic research, rising incidences of genetic disorders, and a continuous push towards personalized medicine and sustainable agricultural practices.

The escalating demand for innovative therapeutic solutions to address complex diseases is driving the adoption of CRISPR across pharmaceutical and biotechnology sectors. In addition, advancements in CRISPR kits, enzymes, and libraries are enabling more efficient and versatile gene-editing capabilities. According to industry reports, the integration of CRISPR technology in drug discovery workflows has significantly shortened development timelines and reduced costs. Furthermore, agricultural applications leveraging CRISPR for crop improvement and pest resistance are gaining momentum, especially in regions aiming to enhance food security. However, ethical concerns, regulatory hurdles, and the high costs associated with gene-editing technologies pose challenges that could moderate the market's pace of expansion.

Geographically, North America holds the largest share in the global CRISPR market as of 2024, owing to its well-established biotech infrastructure, significant funding in genetic research, and the presence of key industry players. The U.S., in particular, leads due to its robust R&D ecosystem and favorable regulatory environment. Europe follows with substantial contributions from countries like Germany, the UK, and France, supported by strong academic research institutions and government initiatives promoting biotech innovation. Meanwhile, the Asia Pacific region is poised for the fastest growth, driven by rising healthcare investments, expanding agricultural biotechnology, and increasing collaborations between local and international biotech firms. Emerging markets such as China and India are capitalizing on CRISPR technology to meet their burgeoning demand for advanced healthcare and agricultural productivity improvements.

Major market players included in this report are:

Broad Institute of MIT and Harvard
Dyno Therapeutics, Inc.
Intellia Therapeutics, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
Takara Bio Inc.
Synthego Corporation
Caribou Biosciences, Inc.
GenScript Biotech Corporation
Integrated DNA Technologies, Inc.
Beam Therapeutics Inc.
Mammoth Biosciences, Inc.
Agilent Technologies, Inc.
Merck KGaA
Novozymes A/S

Global CRISPR Market Report Scope:

Historical Data - 2023, 2024
Base Year for Estimation - 2024
Forecast period - 2025-2035
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

By Product & Services:

Products (CRISPR Kits & Enzymes, CRISPR Libraries, Other Products [Design Tools, Antibodies, Other Reagents])
Services (gRNA Design & Vector Construction, Cell Line Engineering, Screening Services, Other Services [Epigenome Editing, Transcriptional Activation])

By Application:

Drug Discovery & Development
Agriculture
Other Applications (Biofuels, Veterinary)

By End User:

Pharmaceutical & Biotechnology Companies
Academic & Research Institutes

Key Takeaways:

Market Estimates & Forecast for 10 years from 2025 to 2035.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Chapter 1. Global CRISPR Market Report Scope & Methodology

1.1. Research Objective
1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings

Chapter 3. Global CRISPR Market Forces Analysis

3.1. Market Forces Shaping The Global CRISPR Market (2024-2035)
3.2. Drivers
- 3.2.1. Increasing Investments in Genetic Research
- 3.2.2. Rising Incidences of Genetic Disorders
- 3.2.3. Advancements in CRISPR Kits, Enzymes, and Libraries
- 3.2.4. Demand for Innovative Therapeutic Solutions
3.3. Restraints
- 3.3.1. Ethical Concerns Related to Gene Editing
- 3.3.2. Regulatory Hurdles and Compliance Challenges
- 3.3.3. High Costs Associated with CRISPR Technology
3.4. Opportunities
- 3.4.1. Expansion in Agricultural Biotechnology Applications
- 3.4.2. Growth Potential in Emerging Markets (China, India)
- 3.4.3. Integration of CRISPR in Personalized Medicine
- 3.4.4. Collaborations Between Biotech Firms Globally

Chapter 4. Global CRISPR Industry Analysis

4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global CRISPR Market Size & Forecasts by Product & Services 2025-2035

5.1. Market Overview
5.2. CRISPR Kits & Enzymes
5.3. CRISPR Libraries
5.4. Other Products (Design Tools, Antibodies, Other Reagents)
5.5. Services (gRNA Design & Vector Construction, Cell Line Engineering, Screening Services, Other Services [Epigenome Editing, Transcriptional Activation])

Chapter 6. Global CRISPR Market Size & Forecasts by Application 2025-2035

6.1. Market Overview
6.2. Drug Discovery & Development
6.3. Agriculture
6.4. Other Applications (Biofuels, Veterinary)

Chapter 7. Global CRISPR Market Size & Forecasts by End User 2025-2035

7.1. Pharmaceutical & Biotechnology Companies
7.2. Academic & Research Institutes

Chapter 8. Global CRISPR Market Size & Forecasts by Region 2025-2035

8.1. Global CRISPR Market, Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America CRISPR Market
- 8.3.1. U.S. CRISPR Market
  - 8.3.1.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.3.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.3.2. Canada CRISPR Market
  - 8.3.2.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.3.2.2. Application Breakdown Size & Forecasts, 2025-2035
8.4. Europe CRISPR Market
- 8.4.1. UK CRISPR Market
  - 8.4.1.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.4.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.4.2. Germany CRISPR Market
  - 8.4.2.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.4.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.4.3. France CRISPR Market
  - 8.4.3.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.4.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.4.4. Spain CRISPR Market
  - 8.4.4.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.4.4.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.4.5. Italy CRISPR Market
  - 8.4.5.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.4.5.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.4.6. Rest of Europe CRISPR Market
  - 8.4.6.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.4.6.2. Application Breakdown Size & Forecasts, 2025-2035
8.5. Asia Pacific CRISPR Market
- 8.5.1. China CRISPR Market
  - 8.5.1.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.5.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.5.2. India CRISPR Market
  - 8.5.2.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.5.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.5.3. Japan CRISPR Market
  - 8.5.3.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.5.3.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.5.4. Australia CRISPR Market
  - 8.5.4.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.5.4.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.5.5. South Korea CRISPR Market
  - 8.5.5.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.5.5.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.5.6. Rest of APAC CRISPR Market
  - 8.5.6.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.5.6.2. Application Breakdown Size & Forecasts, 2025-2035
8.6. Latin America CRISPR Market
- 8.6.1. Brazil CRISPR Market
  - 8.6.1.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.6.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.6.2. Mexico CRISPR Market
  - 8.6.2.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.6.2.2. Application Breakdown Size & Forecasts, 2025-2035
8.7. Middle East and Africa CRISPR Market
- 8.7.1. UAE CRISPR Market
  - 8.7.1.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.7.1.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.7.2. Saudi Arabia (KSA) CRISPR Market
  - 8.7.2.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.7.2.2. Application Breakdown Size & Forecasts, 2025-2035
- 8.7.3. South Africa CRISPR Market
  - 8.7.3.1. Product & Services Breakdown Size & Forecasts, 2025-2035
  - 8.7.3.2. Application Breakdown Size & Forecasts, 2025-2035

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Broad Institute of MIT and Harvard
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Financial Performance (Subject to Data Availability)
- 9.2.5. Product/Services Port
- 9.2.6. Recent Development
- 9.2.7. Market Strategies
- 9.2.8. SWOT Analysis
9.3. Dyno Therapeutics, Inc.
9.4. Intellia Therapeutics, Inc.
9.5. CRISPR Therapeutics AG
9.6. Editas Medicine, Inc.
9.7. Takara Bio Inc.
9.8. Synthego Corporation
9.9. Caribou Biosciences, Inc.
9.10. GenScript Biotech Corporation
9.11. Integrated DNA Technologies, Inc.
9.12. Beam Therapeutics Inc.
9.13. Mammoth Biosciences, Inc.
9.14. Agilent Technologies, Inc.
9.15. Merck KGaA
9.16. Novozymes A/S